Skip to main content

Table 2 Perioperative patients details

From: St. Jude Medical Trifecta aortic valve: results from a prospective regional multicentre registry

Variablesa All implants (n = 178)
Valve size implanted, n (%)  
 19 mm 31 (17.4)
 21 mm 58 (32.6)
 23 mm 58 (32.6)
 25 mm 24 (13.5)
 27 mm 7 (3.9)
Operative data  
 Isolated AVR, n (%) 81 (45.5)
 CABG, n (%) 63 (35.4)
 ACC time, min 67.9 ± 41.4 (45-95)
 CPB time, min 103.9 ± 45.7 (70-131)
Postoperative data  
 IABP, n (%) 6 (3.4)
 Re-exploration for bleeding, n (%) 7 (3.9)
 Stroke, n (%) 2 (1.1)
 Respiratory failure, n (%) 14 (7.9)
 Acute kidney injury, n (%) 24 (13.5)
 Renal replacement therapy, n (%) 11 (6.2)
 Atrial fibrillation, n (%) 79 (44.4)
 Ventilation, hours 33.8 ± 98.8 (7-24)
 ICU stay, hours 68.5 ± 119.2 (24-60)
 Hospital mortality, n (%) 5 (2.8)
  1. aFor continuous variables, mean ± SD (interquartile range); categorical data, count (percentage)
  2. ACC aortic cross clamp time, AVR aortic valve replacement, CABG coronary artery bypass grafting, CPB cardiopulmonary bypass, IABP intra-aortic balloon pump, ICU intensive care unit